Bolder BioTechnology, Inc.: 2003 Press Release Archive PRESS RELEASES - 2003 Archive 10-9-2003 Wheat Ridge, Colorado Bolder BioTechnology Receives National Cancer Institute Grant... to Develop Platelet-Stimulating Proteins For Treating Thrombocytopenia >>Click here for complete News Release 10-9-2003 Wheat Ridge, Colorado Bolder BioTechnology Receives U.S.... Patent for Long-Acting Growth Hormone Product >>Click here for complete News Release 1-14-2003 Wheat Ridge, Colorado Bolder BioTechnology Awarded Grant From The National Cancer...

Bolder BioTechnology, Inc.: 2002 Press Release Archive PRESS RELEASES - 2002 Archive 11-19-2002 Wheat Ridge, Colorado Bolder BioTechnology Awarded Grant From The National Cancer... Institute To Develop Long-Acting Angiostatin Proteins For Treating Cancer >>Click here for complete News Release 12-11-2002 Wheat Ridge, Colorado Bolder BioTechnology Receives Phase... - People - News - Careers - Contact Us Copyright 2009. Bolder BioTechnology, Inc. All Rights Reserved. Disclaimerpowered by iCita ...

Bolder BioTechnology, Inc. Web Site - News PRESS RELEASES 08-28-2012 Boulder, Colorado Bolder BioTechnology Announces Publication of Data Demonstrating Utility of the Company's... Long-Acting IL-11 Analog to Prevent Renal Ischemia Reperfusion Injury >>Click here for complete News Release 11-3-2010 Boulder, Colorado Bolder BioTechnology Announces $1.2 Million... in Qualifying Therapeutic Discovery Project Grants >>Click here for complete News Release 8-18-2010 Boulder, Colorado Bolder BioTechnology Announces $600,000 Grant from NIH to Study...

Bolder BioTechnology, Inc. Web Site - Company Profile Date: Company Profile Bolder BioTechnology, Inc. uses advanced protein engineering technologies to create proprietary human... these products independently and through strategic alliances with corporate partners. News 08-28-2012 Bolder BioTechnology Announces Publication of Data Demonstrating Utility... of the Companys Long-Acting IL-11 Analog to Prevent Renal Ischemia Reperfusion Injury Details 11-03-2010 Bolder BioTechnology Announces $1.2 Million in Qualifying Therapeutic Discovery...